TNF and juvenile idiopathic arthritis: Methods: Retrospective analysis of prospective data from electronic medical records of JIA patients at the Wilhelmina Children’s Hospital (Utrecht, the Netherlands), aged <18 years between 8 April 2011 and 8 April 2022, and treated with TNF-α bDMARDs, which were discontinued or tapered during this period.